Pharma Mobile Apps: Prescription for Boosting Success
Pharmaceutical marketers today are rushing to build mobile apps at a record pace. Since apps are relatively new for pharma, too often they’re merely the shiny, new toy every brand wants. However, a disciplined strategic approach can quickly boost the likelihood of success.
App development across all industries has skyrocketed. Since the Apple Store launched in mid-2008, 10 billion apps have been downloaded, over 7 billion in the last year. There are now some 400,000 apps available for Apple devices.
Only 10,000 are medical apps, but pharma has also been riding the app wave.
Ernst and Young reports that drug companies spent 78% more last year launching projects that use technology to improve patient health. Half were mobile health apps, compared with just 16% previously.
Why are mobile apps right for pharma? Apps have many compelling benefits, including accessible content without an internet connection, uniquely rich experiences from integrating mobile device functionality, etc. However, app success will remain elusive unless brands leverage knowledge of mobile behavior and best practices, starting with the following:
Pre-App: Mobile-Friendly Sites
Far more of a brand’s audience will visit the website via a mobile browser than ever use an app. Sadly, a 2011 Mediapost audit showed just 19% of pharma sites are mobile-optimized, and Google estimates only slightly higher at 21%. (Note: Acuity Group reported in 2010 that 88% of top retailer websites are not mobile-friendly, so it’s not just a pharma problem.)
Before considering an app, first optimize brand and disease sites for mobile, ensuring the most valuable content is fully accessible. Only after core information, content, and functionality are mobile-friendly is it time to think about apps.
HCPs Before Consumers
Physician apps should usually take priority over consumers, since HCP mobile adoption is accelerating much more rapidly. Manhattan Research reports HCP smart phone penetration at 81%, and half of those use a medical app professionally. iPad ownership among physicians is already 30%, and 38% more plan to purchase by Q4, 2011.
HCP app strategies ought to prioritize mobile-engaged specialties, such as Physician Assistants and ER docs, who have the highest mobile use at 40% (Source: Bulletin Healthcare), vs. Oncologists and Clinical Pathologists, where only 20% and 16%, respectively, use mobile.
Yet, 75% of new Apple medical apps are for patients, who don’t seem overly interested. MobiHealth News reports only 9% of consumers with smartphones ever downloaded an app for managing health. Such low adoption requires that patient health apps focus on segments likely to be receptive, like the 86% of mobile consumers aged 35-44 using apps.
Seize Best App-ortunities
Mobile app possibilities may seem limitless, but many are clear. Half of physician smartphone users already utilize drug reference apps, and one-third conduct mobile CME. PwC reports 57% of HCPs want mobile to monitor patients remotely, supported by 31% of consumers who would allow apps to track personal health.
Physician iPad ownership expands the possibilities, as 40% of HCPs planning to buy are interested in showing images, video, or other info to patients, 40% for writing clinical notes, and 30% for remote patient monitoring.
Pharma apps already meet some of these needs. Merck’s Vree for Diabetes helps type 2 diabetes patients track blood sugar, medications, nutrition intake and activity levels, while Sanofi’s AFib Educator helps HCPs explain the disease to patients. Others innovate in new areas, like GSK/ MedTrust’s Cancertrials App, which helps HCPs locate clinical trials for experimental therapies. (Note: app extensions of currently-regulated medical devices are subject to FDA review.)
Promote New Apps Heavily
With apps, it’s not true that “if you build it, they will come.” In the Apple Store’s early days, most were discovered quickly, without significant promotion. Today, with over 400,000 available, new apps can easily go unnoticed. Of the 10,000 medical apps (far fewer for pharma), most are not ranked, keeping download numbers low.
Without promotion, apps are typically discovered more randomly from App Store browsing, or family/friend recommendations. The most effective promotion engages influential bloggers or app rating sources, which spur higher rankings and download volumes. Prospect and customer outreach also drives app launch success, along with incentives to tell friends. Apps with broad appeal may employ search marketing and online advertising, but these are costly.
Combat “App Apathy”
Downloads do not indicate success, for users lose interest in most apps quickly According to Pinch Media, only 20% of consumers use free apps more than one day after downloading and only 5% use 30 days later. ComScore indicated 1/3 of American consumers have apps on their phones, but only 2/3 of them ever use. One survey indicated only a small portion of patients will use a compliance app 10 days after downloading.
Marketers must stimulate repeat usage to ensure an app’s value is fully experienced. Although physician app re-use is much higher than patients’, driving repeat interaction is critical for all. Common tactics include app messaging, app improvement alerts, feedback requests, or promotions where winning correlates with higher usage.
Pharma apps offer substantial opportunities as mobile adoption accelerates, but brands should avoid jumping blindly into this new frontier. Better aligning app strategies with mobile behavior and best practices is certain to enhance pharma app results.
- Pingback from Latest Best Apps On The App Store News | Ipad To TV App
- Pingback from Quirky App Of The Day: Hit The Apple! – AppAdvice
- Pingback from Mobile Apps Take Priority in Pharma mHealth Push, Particularly For Healthcare Physicians | mHealthWatch
Great insight, Michael. Mobile apps represent an enormous opportunity for the pharma industry and I think it is very important to keep in mind best practices before jumping in head first. What will be interesting to see is how FDA will play a part in monitoring mHealth. If FDA’s lack of guidance with social media channels is any indication, mHealth regulation can be a slow and frustrating process as well. For pharma marketers, it’s imperative to be mindful of how mHealth can positively impact the health care industry—even save lives. Like social media usage, pharma marketers need to see the potential in mHealth, especially how it ultimately allows them to reach their target audience and deliver critical information directly to their fingertips.
- Pingback from Do you know a cheap service to create a mobile website? - Social Media Marketing for Your Local Business — Social Media Marketing for Your Local Business
It would seem that the key is to find out (by way of surveying) what your current customers would like to see coming from any app you develop. That would take care of your concerns about jumping blindly into the new frontier. The sky is the limit with services you could provide like creating an app for a specific aliment instead of the broad “health term” avenue. Drill down to specific health issues. Hope that helps… Thanks for enlightening us with knowledge about Pharma Mobile Apps.
- Pingback from Zco to Sponsor Pharmaceutical Communications Conference
Leave a Comment
- If It Can’t Be Measured, It Can’t Be Improved: The Ongoing Case for Performance in Digital
- What is value exchange and how is it an answer to ad blocking and fraud?
- Advertiser Perceptions Report: 2016 Upfront/NewFronts Have Renewed Influence On Advertiser Spending
- Going Native: What Makes It Work, What Makes It Fail
- 3 Steps for Evaluating the Best Results Across Retargeters